News & Updates

Show Multimedia Only

Amiodarone plus apixaban/rivaroxaban ups bleeding-related hospitalizations in older AF patients

27 May 2023

Use of amiodarone in older patients with atrial fibrillation (AF) who are being treated with apixaban or rivaroxaban results in a higher risk of bleeding-related hospitalizations compared with the use of flecainide or sotalol, reports a study.

27 May 2023

Serum ADMA levels linked to circadian BP variability in glaucoma

27 May 2023

Serum levels of asymmetric dimethylarginine (ADMA) seem to play a major role in the disturbance of circadian blood pressure (BP) variability in patients with glaucoma, suggests a recent study.

27 May 2023

Long-term ACS outcomes similar between TiNO-coated and everolimus-eluting stents

27 May 2023

Neither titanium-nitride-oxide (TiNO)–coated stents nor third-generation everolimus-eluting stents (EES) are necessarily better than the other in the treatment of patients with acute coronary syndromes (ACS), with a study showing no significant difference in long-term outcomes following placement of TiNO-coated stents or EES.

27 May 2023

HCT treatment tied to lower cancer risk, except skin cancer

26 May 2023

Treatment with hydrochlorothiazide (HCT) contributes to a lower all-cancer risk and a slightly higher skin cancer risk compared with alternative diuretics, reports a study involving a German population.

26 May 2023

Pulsed field ablation benefits most patients with AF treated in usual clinical care

23 May 2023

Catheter ablation using pulsed field energy leads to freedom from atrial arrhythmia in many patients with atrial fibrillation (AF), according to data from MANIFEST-PF*.

23 May 2023

CHIP predicts adverse outcomes in atherosclerotic CVD

23 May 2023

Clonal haematopoiesis of indeterminate potential (CHIP) appears to independently contribute to adverse outcomes in individuals with established atherosclerotic cardiovascular disease (ASCVD), reveals a recent study, noting the high risks in TET2 and SF3B1/SRSF2/U2AF1 CHIP.

23 May 2023

Eplontersen promising for hereditary ATTRv-PN

23 May 2023 by

Eplontersen, a ligand-conjugated antisense (LICA) investigational agent designed to reduce transthyretin (TTR) production or TTR protein, ably halts neuropathy progression and improves quality of life (QoL) in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) in the phase III NEURO-TTRansform trial.

23 May 2023

Natriuretic response to acetazolamide predicts decongestion in acute heart failure

22 May 2023

A robust association exists between increased natriuresis and successful decongestion with acetazolamide in patients with acute decompensated heart failure (ADHF), suggests a study.

22 May 2023

Takotsubo syndrome tied to impaired LV contractility, shortened systolic period

21 May 2023

Patients with Takotsubo syndrome (TTS), a reversible form of heart failure with incompletely understood pathophysiology, may exhibit reduced cardiac contractility, shortened systolic period, inefficient energetics, and prolonged active relaxation but unaffected diastolic passive stiffness, a study has shown.

21 May 2023

Large for gestational age tied to higher cardiometabolic risks

17 May 2023

Individuals born large for gestational age (LGA) are more likely to develop obesity and metabolic syndrome later in life than those born appropriate for gestational age, suggests a study.

17 May 2023

News & Updates

Showing Cardiology articles

Showing

Specialty:

Amiodarone plus apixaban/rivaroxaban ups bleeding-related hospitalizations in older AF patients

Serum ADMA levels linked to circadian BP variability in glaucoma

Long-term ACS outcomes similar between TiNO-coated and everolimus-eluting stents

HCT treatment tied to lower cancer risk, except skin cancer

Pulsed field ablation benefits most patients with AF treated in usual clinical care

CHIP predicts adverse outcomes in atherosclerotic CVD

Eplontersen promising for hereditary ATTRv-PN

Natriuretic response to acetazolamide predicts decongestion in acute heart failure

Takotsubo syndrome tied to impaired LV contractility, shortened systolic period

Large for gestational age tied to higher cardiometabolic risks